Low disease activity state in juvenile-onset systemic lupus erythematosus
CONCLUSION: Targeting LLDAS in jSLE, even with long-term, low-dose corticosteroid use, seems to be an achievable goal in clinical practice.PMID:34723709 | DOI:10.1177/09612033211054399
Source: Lupus - Category: Rheumatology Authors: Kubra Ozturk Sen ğul Caglayan Ayse Tanatar Esra Baglan Gulcin Yener Otar Gulsah Kavrul Kayaalp Serife Gul Karadag Ferhat Demir Hafize Emine Sonmez Semanur Ozdel Mustafa Cakan Nuray Aktay Ayaz Betul Sozeri PeRA-Research Group Source Type: research
More News: Allergy & Immunology | Children | Corticosteroid Therapy | Lupus | Middle East Health | Pediatrics | Proteinuria | Rheumatology | Study | Turkey Health